Special Issue "Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy"
- PMID: 32245003
- PMCID: PMC7150848
- DOI: 10.3390/v12030341
Special Issue "Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy"
Abstract
Members of the Morbillivirus genus are enveloped, negative-strand RNA viruses that include a number of highly contagious pathogens important to humans and animals. They are known to be transmitted via the respiratory route and cause febrile diseases that can be fatal. Despite the availability of attenuated vaccines against several members, these viruses remain responsible for significant morbidity and mortality in their natural hosts worldwide. The development of molecular biology techniques over the past decades has helped increase the understanding of morbillivirus pathogenesis and explore the possibility to engineer their genomes as viral vectors. This Special Issue of Viruses explores recent advances in recombinant morbilliviruses platforms, especially measles virus (MV) and canine distemper virus (CDV), for novel vaccine development and oncolytic virotherapy against cancers. Topics in this special issue include parameters involved during the viral vector production, strategies of viral vector engineering, and the underlying mechanisms of the therapeutic effects exhibited by these vectors.
Conflict of interest statement
The author declares no conflict of interest.
Similar articles
-
Viral Pathogenesis, Recombinant Vaccines, and Oncolytic Virotherapy: Applications of the Canine Distemper Virus Reverse Genetics System.Viruses. 2020 Mar 20;12(3):339. doi: 10.3390/v12030339. Viruses. 2020. PMID: 32244946 Free PMC article. Review.
-
Evolutionary characteristics of morbilliviruses during serial passages in vitro: Gradual attenuation of virus virulence.Comp Immunol Microbiol Infect Dis. 2016 Aug;47:7-18. doi: 10.1016/j.cimid.2016.05.007. Epub 2016 May 26. Comp Immunol Microbiol Infect Dis. 2016. PMID: 27477502 Review.
-
Measles vaccination: Threat from related veterinary viruses and need for continued vaccination post measles eradication.Hum Vaccin Immunother. 2018 Jan 2;14(1):229-233. doi: 10.1080/21645515.2017.1403677. Epub 2017 Dec 14. Hum Vaccin Immunother. 2018. PMID: 29173050 Free PMC article. Review.
-
Measles virus.Hum Vaccin Immunother. 2015;11(1):21-6. doi: 10.4161/hv.34298. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483511 Free PMC article. Review.
-
Involvement of morbilliviruses in the pathogenesis of demyelinating disease.Rev Med Virol. 2007 Jul-Aug;17(4):223-44. doi: 10.1002/rmv.526. Rev Med Virol. 2007. PMID: 17410634 Review.
References
-
- Ammour Y., Ryabaya O., Shchetinina Y., Prokofeva E., Gavrilova M., Khochenkov D., Vorobyev D., Faizuloev E., Shohin I., Zverev V.V., et al. The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus. Viruses. 2020;12:173. doi: 10.3390/v12020173. - DOI - PMC - PubMed
-
- Backhaus P.S., Veinalde R., Hartmann L., Dunder J.E., Jeworowski L.M., Albert J., Hoyler B., Poth T., Jager D., Ungerechts G., et al. Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists. Viruses. 2019;11:914. doi: 10.3390/v11100914. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous